Paras Healthcare IPO Shares List at ₹720 on NSE and BSE, Debut at 3.90% Premium

Paras Healthcare Ltd. shares made their stock market debut on Wednesday, October 28, 2026, listing at ₹720 per share on the National Stock Exchange (NSE), representing a premium of 3.90% over the IPO issue price of ₹693 per share. On the Bombay Stock Exchange (BSE), the stock also opened at ₹720, reflecting the same listing premium of 3.90%.

The stock opened ₹27 above the issue price on both exchanges. Investors who received shares through the IPO allotment recorded a gain at the opening price, before applicable transaction charges and taxes. Following the listing, Paras Healthcare shares traded at ₹740.25 as of 11:07 AM IST, with an intraday high of ₹749 and a low of ₹706.

The listing followed the company's ₹1,450 crore initial public offering, which opened for subscription on October 21, 2026, and closed on October 23, 2026. The public issue received an overall subscription of 2.23 times, with the Qualified Institutional Buyers (QIBs) category recording the highest subscription at 3.09 times. The IPO price band was fixed at ₹660 to ₹693 per share.

Paras Healthcare Ltd. is an Indian hospital operator providing multi-speciality healthcare services. The company operates hospitals under the Paras Health brand, with a presence across North India, Bihar and Jharkhand. Its services cover clinical specialties, medical treatments, surgical procedures and hospital-based healthcare.

Paras Healthcare IPO Listing Details

Paras Healthcare IPO was a ₹1,450 crore book-built issue comprising a fresh issue of 72,15,007 equity shares aggregating ₹500 crore and an offer for sale of 1,37,08,513 equity shares worth ₹950 crore. The equity shares have a face value of ₹1 each.

The proceeds from the fresh issue are intended to be used primarily for repayment or prepayment of certain borrowings and other corporate purposes. The company will not receive proceeds from the offer-for-sale component, as those funds will go to the existing shareholders selling their equity stakes, after applicable expenses and taxes.

The IPO price band was fixed at ₹660 to ₹693 per equity share, with a minimum application lot of 21 shares. At the upper end of the price band, the minimum investment required from an Individual Investor was ₹14,553.

The IPO opened for subscription on October 21, 2026, and closed on October 23, 2026. The basis of allotment was scheduled for October 26, followed by the initiation of refunds and credit of shares to successful applicants' demat accounts on October 27, 2026.

The company raised ₹652.50 crore from anchor investors ahead of the public subscription period. The anchor investor bidding took place on October 19, 2026. The offering included both fresh equity issuance and the sale of existing equity shares by shareholders.

The IPO received an overall subscription of 2.23 times. Qualified Institutional Buyers subscribed 3.09 times their allocated portion, while Individual Investors subscribed 2.00 times. The Non-Institutional Investors category was subscribed 0.66 times.

On October 28, 2026, Paras Healthcare shares listed at ₹720 on both NSE and BSE, representing a premium of 3.90% over the issue price. Following the opening, the stock traded at ₹740.25, reflecting an increase of 6.82% compared with the IPO price.

- Issue Price: ₹693 per share
- NSE Listing Price: ₹720 per share
- BSE Listing Price: ₹720 per share
- NSE Listing Premium: 3.90%
- BSE Listing Premium: 3.90%
- Trading Price: ₹740.25 per share
- Change From Issue Price at NSE Listing: +3.90%
- Change From Issue Price at BSE Listing: +3.90%
- Change From Issue Price at Reported Trading Price: +6.82%
- Intraday High: ₹749
- Intraday Low: ₹706
- Trading Volume: 56,50,881 shares
- Market Capitalisation: ₹8,010 crore
- Overall Subscription: 2.23 times
- Issue Size: ₹1,450 crore
- Fresh Issue: 72,15,007 equity shares, aggregating ₹500 crore
- Offer for Sale: 1,37,08,513 equity shares, aggregating ₹950 crore
- Price Band: ₹660 to ₹693 per share
- Lot Size: 21 shares
- Minimum Investment: ₹14,553
- IPO Open Date: October 21, 2026
- IPO Close Date: October 23, 2026
- Listing Date: October 28, 2026
- Exchange: NSE and BSE

First-Day Trading Performance

Paras Healthcare share price began trading above its IPO issue price on both NSE and BSE on October 28, 2026.

Listing Price: On NSE, the stock opened at ₹720 per share, compared with the IPO issue price of ₹693, resulting in a premium of ₹27 per share, or 3.90%.

On BSE, Paras Healthcare shares also opened at ₹720 per share, representing a premium of ₹27, or 3.90%, over the issue price.

Listing Return: Investors allotted one lot of 21 shares at the issue price of ₹693 invested ₹14,553. At the NSE listing price of ₹720, the value of one lot stood at ₹15,120, representing a gain of ₹567 before applicable charges and taxes.

At the BSE listing price of ₹720, the corresponding lot value also stood at ₹15,120, translating into a gain of ₹567 before charges and taxes.

At the reported trading price of ₹740.25, the value of one lot increased to ₹15,545.25, representing a gain of ₹992.25 over the original application amount, before applicable charges and taxes.

Opening Performance: Following the debut, Paras Healthcare shares touched an intraday high of ₹749, representing an increase of ₹56 per share, or 8.08%, over the IPO issue price.

The stock recorded an intraday low of ₹706, which was ₹13, or 1.88%, above the issue price. The difference between the intraday high and low stood at ₹43 per share.

As of 11:07 AM IST, the stock traded at ₹740.25, which was ₹20.25 above its listing price of ₹720. This represented an increase of 2.81% over the opening price and 6.82% over the IPO issue price.

Trading volume reached 56,50,881 shares during the morning session. At the reported trading price, the company's market capitalisation stood at ₹8,010 crore.

The opening premium followed an IPO that received 2.23 times overall subscription. Institutional investors recorded the highest participation among the main investor categories, with the QIB portion subscribed 3.09 times, while the NII category attracted 0.66 times subscription.

The opening prices on both exchanges reflected gains over the issue price. However, these returns represent the opening and intraday trading prices and do not account for subsequent movements during the remainder of the session.

Paras Healthcare IPO Subscription Status

The Paras Healthcare IPO received an overall subscription of 2.23 times by the close of bidding on October 23, 2026.

The public issue attracted bids for 2,69,43,714 shares against 1,20,83,331 shares available for subscription, excluding the anchor investor portion.

Qualified Institutional Buyers recorded the highest subscription at 3.09 times, followed by Individual Investors at 2.00 times. The Non-Institutional Investors category was subscribed 0.66 times.

Within the NII category, larger applications above ₹10 lakh recorded subscription of 0.59 times, while smaller NII applications between ₹2 lakh and ₹10 lakh were subscribed 0.80 times.

The QIB category recorded the highest subscription multiple, with institutional investors bidding for more than three times the shares allocated to the category. Individual Investors subscribed twice their reserved portion, while the NII category remained below full subscription.

The IPO opened on October 21, 2026, receiving overall subscription of 0.15 times on Day 1. Subscription increased to 0.34 times on Day 2, October 22, before reaching 2.23 times on the final day of bidding.

The final subscription figures reflected participation across the major investor categories during the three-day bidding period. The issue subsequently completed its allotment process ahead of the October 28 stock market listing.

About Paras Healthcare Ltd.

Paras Healthcare Limited is a Gurugram-based hospital operator providing tertiary and quaternary healthcare services through its network of multi-speciality hospitals under the Paras Health brand. The company was incorporated in December 1987 and established its first hospital in Gurugram, Haryana, in 2006.

As of March 31, 2026, the company operated eight hospitals with an aggregate bed capacity of 2,211 beds across five states and one union territory. Its network includes hospitals in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand and Srinagar in Jammu and Kashmir.

The company provides healthcare services across several clinical specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, sports injury management and renal sciences. Its hospital network offers advanced medical treatments, diagnostic services, surgical procedures and critical care facilities.

Paras Healthcare operates a clinical specialty-led hospital platform focused on complex medical procedures and specialised healthcare treatments. Its services include inpatient care, outpatient consultations, intensive care and advanced surgical interventions across its hospital network.

The company's healthcare infrastructure includes specialised diagnostic and treatment equipment used in oncology, cardiac care, neurology and other medical disciplines. Its hospitals provide medical services supported by physicians, surgeons, nursing professionals and allied healthcare staff.

For the financial year ended March 31, 2026, Paras Healthcare reported revenue from operations of ₹1,605.95 crore, compared with ₹1,294.1 crore in the previous financial year. The company recorded a net profit of ₹43.83 crore in FY2026, compared with a net loss of ₹57.98 crore in FY2025.

Paras Healthcare has outlined plans to expand its hospital network through additional facilities in Gurugram and Ludhiana. The proposed additions include a 300-bed hospital in Gurugram and a hospital with a capacity of up to 500 beds in Ludhiana, subject to their respective development and operational timelines.

The company's operations are concentrated in North India, Bihar and Jharkhand, where its healthcare services address demand for specialised hospital treatments and advanced medical care. Its business performance is influenced by patient volumes, hospital occupancy, treatment mix, operating costs and expansion of its healthcare infrastructure.

The company's ₹1,450 crore IPO comprised a ₹500 crore fresh issue and a ₹950 crore offer for sale by existing shareholders. The fresh issue proceeds are intended primarily for repayment of borrowings and general corporate purposes, while the offer-for-sale proceeds will go to the selling shareholders.

The listing on NSE and BSE provides a public trading platform for Paras Healthcare's equity shares following the completion of its initial public offering.